Research Library

Browse the science behind optimization.

Peptides, metabolic health, longevity, recovery, mitochondria, skin biology, and clinical research — organized for readers who want evidence over hype.

Search the research

Featured research

Three interconnected receptor structures representing GLP-1, GIP, and glucagon pathways

Metabolic Health / Clinical Research·10 min read·September 17, 2026

Retatrutide: Why Researchers Are Studying Three Metabolic Targets

The triple-agonist concept links GLP-1, GIP, and glucagon receptor activity — a research strategy designed to test whether coordinated metabolic signaling can do more than one pathway alone.

Three molecular receptor panels showing one, two, and three target concepts

Metabolic Health / Clinical Research·9 min read

One Target. Two Targets. Three Targets.

The evolution of incretin-based metabolic research — from GLP-1 receptor agonism to dual and triple receptor strategies.

Liver-centered metabolic pathway visualization with anatomical and molecular elements

Metabolic Health / Clinical Research·8 min read

Why Add Glucagon?

The third target in retatrutide may be the most interesting — and the easiest to oversimplify.

Copper molecular structures interacting with collagen-like tissue

Skin & Aging / Peptides·8 min read

Copper Ions, Peptides and the Science of Rejuvenation

Copper-binding peptides such as GHK-Cu are biologically interesting, but 'rejuvenation' is a marketing umbrella — not a single proven outcome.

Abdominal CT-inspired anatomy combined with pituitary and GHRH pathway visualization

Clinical Research / Metabolic Health·10 min read

Tesamorelin: A Peptide With Real Human Clinical Data

Tesamorelin has human evidence in specific populations and indications — which is exactly why it should not be presented as a general-purpose weight-loss peptide.

Axial abdominal anatomy showing distinct internal and external fat compartments

Metabolic Health / Clinical Research·8 min read

Visceral Fat Isn’t Just ‘Belly Fat’

Where fat is stored changes the biology — and helps explain why researchers measure visceral and subcutaneous adipose tissue separately.

Macro mitochondrial structure with internal membrane folds and peptide-targeting motif

Mitochondria / Longevity·9 min read

SS-31: Targeting the Mitochondria

Elamipretide research focuses on mitochondrial membranes and cardiolipin — a compelling mechanism that still should not be translated into broad longevity claims.

Scientific papers and data arranged as an ascending evidence ladder

Evidence & Research Literacy / Clinical Research·10 min read

Not All Peptide Evidence Is Equal

Cell studies, animal studies, observational data, controlled human trials, and replication all answer different questions. Promising is not the same as proven.

Blurred online claims dissolving into structured clinical research papers and charts

Evidence & Research Literacy / Clinical Research·8 min read

‘Backed by Science’ — But What Kind of Science?

Everyone says it’s backed by science. That phrase does not tell you whether the evidence is a petri-dish experiment, a mouse study, or a replicated human trial.

Social media noise transitioning into clean scientific literature and molecular diagrams

Evidence & Research Literacy / Peptides·8 min read

Peptides Are Everywhere. Good Information Isn’t.

The mission of Half-Life Optimization: separate mechanism, evidence, limitations, regulatory status, and unanswered questions from social-media certainty.

Research paper with highlighted sections and analytical charts on a charcoal desk

Evidence & Research Literacy / Clinical Research·9 min read

How to Read a Peptide Study Without Getting Fooled

A practical field guide for reading peptide papers: model, sample size, controls, endpoints, duration, statistics, replication, and whether the claim matches the data.

A peptide binding to a membrane receptor in a refined molecular visualization

Peptides / Clinical Research·8 min read

How Can Such a Small Molecule Change a Biological Signal?

Peptides often work because cells are built to listen for small molecular messages — but receptor pharmacology is more complex than a simple lock and key.

Laboratory mouse research transitioning into human clinical research imagery

Evidence & Research Literacy / Clinical Research·9 min read

Why Peptides Can Look Incredible in Mice — and Fail in Humans

Animal models are essential to translational research, but species differences, dose, metabolism, endpoints, and study conditions can all break the bridge to humans.

Clinical trial documents, participant silhouettes, and abstract data visualization

Clinical Research / Evidence & Research Literacy·10 min read

What Makes a Human Trial Convincing?

Randomization, controls, blinding, sample size, endpoints, duration, statistical significance, clinical significance, and replication — in plain language.

Evidence & Research Literacy·13 min read

How to read a peptide Certificate of Analysis

A field guide to the document every research-peptide seller publishes and almost no reader interrogates. Batch numbers, HPLC, mass spec, and the difference between a real third-party report and a decorative PDF.

Evidence & Research Literacy·9 min read

What 'research use only' actually means

Four words that started life describing bench reagents and now travel on the outside of consumer-facing peptide vials. The legal weight is smaller than the label implies.

Evidence & Research Literacy·10 min read

Why third-party purity testing matters

Counterfeits, contaminants, and the reason 'looks like the label' is not evidence of anything.

Scientific literature and molecular visualization arranged on a charcoal editorial desk

Clinical Research / Peptides·11 min read

BPC-157: Promising Research vs. Proven Evidence

Why BPC-157's online reputation is much larger than its controlled human evidence base — and how to read the gap without dismissing the science.

Peptides / Recovery·10 min read

TB-500: what the research has actually examined

A synthetic fragment of thymosin beta-4 with a preclinical footprint in tissue repair models, an equine racing regulatory history, and almost no controlled human data.

A copper ion interacting with peptide and collagen-like tissue structures

Skin & Aging / Peptides·10 min read

GHK-Cu: The Peptide Your Skin Already Knows

A naturally occurring copper-binding tripeptide with a long biochemistry, a visible cosmetic literature, and important limits on systemic claims.

Peptides·11 min read

CJC-1295 and Ipamorelin: what the research has examined

A GHRH analog and a selective ghrelin-mimetic. The short-term pharmacodynamic story is well characterized; the chronic clinical story for the marketed use case is not.

Metabolic Health / Longevity·13 min read

GLP-1 Compounds in Longevity and Performance Circles

The peer-reviewed program for semaglutide and tirzepatide is one of the largest in modern pharmacology. The way it gets discussed in longevity and biohacking media is a different document.

Peptides·10 min read

The peptide reclassification, explained

The February 2026 regulatory changes in plain language: what shifted, what did not, and which categories of buyer and seller the changes actually reach.

Metabolic Health·13 min read

The GLP-1 moment reaches sport

What started as a diabetes and obesity story is now turning up in locker rooms, broadcast booths, and anti-doping monitoring lists.

Amino-acid chains assembling into a peptide on cream and charcoal editorial surfaces

Peptides·9 min read

What Is a Peptide?

A clear guide to amino acids, peptide chains, proteins, signaling, receptors, and why researchers study peptides in the first place.

Metabolic Health·10 min read

Serena Williams and the postpartum GLP-1 conversation

An August 2025 disclosure, a paid telehealth partnership, and a public reframe of weight as biology rather than willpower.

Metabolic Health·10 min read

Oprah Winfrey and the 'tool, not willpower' reframe

A December 2023 confirmation, an ABC primetime special, and a board resignation to remove a conflict of interest.

Athletic recovery imagery blended with molecular research diagrams

Recovery / Peptides·12 min read

BPC-157: Why Is Everyone Talking About It?

What BPC-157 is, why it became popular in recovery circles, what preclinical research has investigated, and why the human evidence remains limited.

Metabolic Health·9 min read

Elon Musk, 'Ozempic Santa,' and the access debate

A Christmas 2024 social-media post, a follow-up correction, and an argument for making GLP-1 drugs cheap.

Peptides / Recovery·11 min read

Sleep, recovery, and the secretagogue story

Growth hormone pulses during deep sleep. That fact gets stretched a long way in marketing copy for peptides that target the same axis.

Metabolic Health·9 min read

Shaquille O'Neal's GLP-1 — for sleep apnea, not a weight story

A 2011 Harvard sleep study, a Zepbound prescription, and an Eli Lilly campaign disclosure.

Evidence & Research Literacy·9 min read

'Research use only,' explained

Four words that do a lot of regulatory and legal work — and that mean less than the label implies.

Peptides·10 min read

Why third-party testing matters

Identity, potency, sterility, endotoxin. The four words you should know before reading a Certificate of Analysis.

Peptides·11 min read

What 'compounded' actually means

The word covers a regulated pharmacy practice, an emergency shortage workaround, and — in 2025 — an FDA enforcement target. They are not the same thing.

The Half-Life Brief

Research worth reading. No hype.

Get evidence-focused breakdowns of peptide research, metabolic health, longevity, performance and emerging science.

Research summaries, not medical advice. Unsubscribe anytime.